土耳其總統埃爾多安：我希望COP31大會將成爲應對氣候變化鬥爭的轉折點。

Fed official Logan said it would be reasonable to pause after two more rate hikes to assess whether further action is needed.

At its Q3 2026 results briefing, Botuo Biotech said it will retain POCT rapid diagnostics as its core business, expand its product matrix, accelerate domestic and overseas registrations/certifications, and advance a microfluidic fluorescent detection platform and high-end microfluidic chip reagent development to strengthen POCT competitiveness. The company said it is also deploying an industrial investment platform—via equity stakes, M&A and participation in industry funds—to explore frontier medical areas including brain–computer interfaces (BCI) and AI-driven healthcare, aiming to open long-term potential growth avenues.